Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Retatrutide shows potential for greater efficacy through triple-agonism but awaits Phase 3 results Best For Recommendations# Currently Available Treatment# Recommendation : Tirzepatide Reason : FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential# Recommendation : Retatrutide Reason : Phase 2 data showed 24.2% weight loss at 48 weeks, exceeding tirzepatide's results, though Phase 3 confirmation is pending Non-Alcoholic Fatty Liver Disease# Recommendation : Retatrutide Reason : Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management# Recommendation : Tirzepatide Reason : Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Further Reading# Which Is Better For
Melatonins impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease
Sleep apnea risk in subjects with asthma with or without comorbid rhinitis
For immediate support for your overall wellness during your weight loss journey, you can also explore our quick-access supplements
Staying adequately hydrated, avoiding rapid changes in posture, and ensuring a balanced diet can help
Semaglutide administration led to a decrease in BMD: 2.1% in the lumbar spine ( p = 0.01), 2.6% in the total hip ( p = 0.001), and 1.5% in the tibial volumetric BMD ( p = 0.003)
US$ 28.37
US$ 27.45
US$ 29.74
US$ 25.79
US$ 21.88
US$ 28.50
US$ 20.32
US$ 21.71
US$ 20.84
US$ 26.64
